Targeting 5-lipoxygenase signaling pathways to reverse drug resistance in cancer

Alfonso Catalano; Antonio Procopio

doi:10.2174/157018006778194817

Targeting 5-lipoxygenase signaling pathways to reverse drug resistance in cancer

Alfonso Catalano, Antonio Procopio

Istituto Nazionale di Riposo e Cura per Anziani V.E. II

Research output: Contribution to journal › Article › peer-review

Abstract

5-Lipoxygenase, which leads to the biosynthesis of proinflammatory lipid mediators, is involved in the pathogenesis of cancer. Experimental studies have demonstrated that 5-lipoxygenase inhibitors have antitumoral properties. Here, we describe the compelling evidence that 5-lipoxygenase inhibition is a rational therapy for certain cancers and for adjuvant approaches to cancer therapy.

Original language	English
Pages (from-to)	459-461
Number of pages	3
Journal	Letters in Drug Design and Discovery
Volume	3
Issue number	7
DOIs	https://doi.org/10.2174/157018006778194817
Publication status	Published - 2006

Keywords

5-lipoxygenase
Cancer therapy
Eicosanoids
Lipoxygenase inhibitors

ASJC Scopus subject areas

Pharmaceutical Science
Drug Discovery
Molecular Medicine

Access to Document

10.2174/157018006778194817

Fingerprint Dive into the research topics of 'Targeting 5-lipoxygenase signaling pathways to reverse drug resistance in cancer'. Together they form a unique fingerprint.

Cite this

@article{81d8372924fe49eeabc62d9c63bda5b4,

title = "Targeting 5-lipoxygenase signaling pathways to reverse drug resistance in cancer",

abstract = "5-Lipoxygenase, which leads to the biosynthesis of proinflammatory lipid mediators, is involved in the pathogenesis of cancer. Experimental studies have demonstrated that 5-lipoxygenase inhibitors have antitumoral properties. Here, we describe the compelling evidence that 5-lipoxygenase inhibition is a rational therapy for certain cancers and for adjuvant approaches to cancer therapy.",

keywords = "5-lipoxygenase, Cancer therapy, Eicosanoids, Lipoxygenase inhibitors",

author = "Alfonso Catalano and Antonio Procopio",

year = "2006",

doi = "10.2174/157018006778194817",

language = "English",

volume = "3",

pages = "459--461",

journal = "Letters in Drug Design and Discovery",

issn = "1570-1808",

publisher = "Bentham Science Publishers B.V.",

number = "7",

}

TY - JOUR

T1 - Targeting 5-lipoxygenase signaling pathways to reverse drug resistance in cancer

AU - Catalano, Alfonso

AU - Procopio, Antonio

PY - 2006

Y1 - 2006

N2 - 5-Lipoxygenase, which leads to the biosynthesis of proinflammatory lipid mediators, is involved in the pathogenesis of cancer. Experimental studies have demonstrated that 5-lipoxygenase inhibitors have antitumoral properties. Here, we describe the compelling evidence that 5-lipoxygenase inhibition is a rational therapy for certain cancers and for adjuvant approaches to cancer therapy.

AB - 5-Lipoxygenase, which leads to the biosynthesis of proinflammatory lipid mediators, is involved in the pathogenesis of cancer. Experimental studies have demonstrated that 5-lipoxygenase inhibitors have antitumoral properties. Here, we describe the compelling evidence that 5-lipoxygenase inhibition is a rational therapy for certain cancers and for adjuvant approaches to cancer therapy.

KW - 5-lipoxygenase

KW - Cancer therapy

KW - Eicosanoids

KW - Lipoxygenase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=33748567799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748567799&partnerID=8YFLogxK

U2 - 10.2174/157018006778194817

DO - 10.2174/157018006778194817

M3 - Article

AN - SCOPUS:33748567799

VL - 3

SP - 459

EP - 461

JO - Letters in Drug Design and Discovery

JF - Letters in Drug Design and Discovery

SN - 1570-1808

IS - 7

ER -